Briefing: GOP Senator Investigates FDA Over Rare Disease Drug Rejections

Summary

• Sen. Ron Johnson is questioning the FDA's drug approval process.
• Focus on treatments for rare diseases that have been rejected.
• Discussion with FDA Commissioner Marty Makary highlights concerns.

Key Facts

Fact	Value
Senator	Ron Johnson
Agency	FDA
Date of Investigation	March 10, 2026

Sources

• STAT: https://www.statnews.com/2026/03/10/ron-johnson-investigating-fda-rare-disease-drug-denials/?utm_campaign=rss